N
3.42
0.07 (2.09%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 看涨 |
| Biotechnology (全球的) | 混合的 | 看涨 | |
| 股票 | NRX Pharmaceuticals, Inc. | 混合的 | 看涨 |
AIStockmoo 评分
-0.5
| 分析师共识 | NA |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 1.0 |
| 技术振荡指标 | -0.5 |
| 平均 | -0.50 |
|
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Core |
| 内部持股比例 | 15.88% |
| 机构持股比例 | 13.34% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Bleakley Financial Group, Llc | 30 Jun 2026 | 117,216 |
| One Wealth Management Investment & Advisory Services, Llc | 30 Jun 2026 | 43,309 |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合